Premier Alternatives

Stimusil

Wilmington, DE · Founded 2021 · Privately Held (backing)

Operator of a medical device company intended to develop proprietary methods for subdermal photobiomodulation. Stimusil is based in Wilmington, DE and was founded in 2021. Its last reported valuation was $29.2 million in Aug 2023. It has raised $10.3 million across 3 recorded rounds; the latest was a $599,988 seed round in Dec 2024.

Last reported valuation
$29.2M
Oct 2026
Priced at
—
Total raised
$10.3M
Last round
Seed Round
Dec 2024
How much has Stimusil raised?
$10.3Macross 3 recorded rounds · Jul 2022 – Dec 2024

Most recently, Stimusil raised $600K in its Seed Round (Dec 2024).

Free account
More of Stimusil with a free account
  • ·Watch Stimusil: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Stimusil round by round

3 rounds
Dec 2024Seed Round$600KSEC filing▮
2 investors participated
Apr 2024Seed Round$1.1MSEC filing▮
7 investors participated
Jul 2022Seed Round$575KSEC filing▮
12 investors participated

How much has Stimusil raised?

Stimusil has raised $10.3 million in total; 3 of its rounds are on record, from 2022 on. The largest on record was a $599,988 seed round in Dec 2024.

Stimusil has filed 5 Form Ds with the SEC since 2022, most recently in Mar 2025 ($599,988 sold to 2 investors).

Stimusil investors

3 investors are on record for Stimusil, including Toubkal Partners, Gen Ilac Ve Saglik and Northwestern University. The seed round in Dec 2024 drew 2 investors.

For fundraisers
Raising for a company like Stimusil?

3 investors have backed Stimusil.

See all 3 investors →

Frequently asked about Stimusil

How much has Stimusil raised?
Stimusil has raised $10.3M in total across 3 recorded funding rounds.
When was Stimusil's last funding round?
Stimusil's most recent recorded round was Seed Round in Dec 2024, raising $600K.